An analysis of recent events and newly published data on Chymopapain and the technique of Chemonucleolysis including an objective analysis of clinical and basic research as well as the circumstances leading to the Food & Drug Administration curtailment of the use of Chymopapain in the United States, indicate that the drug should be reapproved for investigational use.
|Number of pages||5|
|Journal||Clinical Orthopaedics and Related Research|
|State||Published - Dec 1 1977|
ASJC Scopus subject areas
- Orthopedics and Sports Medicine